Oaktree Capital Management »

Bioxcel Therapeutics shares owned by Oaktree Capital Management

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Oaktree Capital Management from 13F filings

Historical chart of Oaktree Capital Management investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Oaktree Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $617k 241k 2.56
2025-06-30 $437k 241k 1.81

More positions owned by Oaktree Capital Management

Torm Common Stock (TRMD)
Expand Energy Corp Common Stock (EXE)
Garrett Motion Common Stock (GTX)
Anglogold Ashanti Common Stock (AU)
Viper Energy Common Stock (VNOM)
State Street Corp Etf Put Option (SPY)
Talen Energy Corp Common Stock Call Option (TLN)
Telephone And Data Systems Common Stock (TDS)
Oracle Corp Common Stock Put Option (ORCL)
Sunopta Common Stock (STKL)
Core Scientific Common Stock (CORZ)
Barrick Mining Corp Common Stock (B)
Liberty Global Common Stock (LBTYA)
Ftai Aviation Common Stock (FTAI)
Cemex Sab De Cv Common Stock (CX)

View all positions for Oaktree Capital Management

Top funds holding Bioxcel Therapeutics

Millennium Management
Oaktree Capital Management
FMR
Vanguard Group
Geode Capital Management
XTX Topco
BlackRock
State Street Corporation
UBS Group
Oaktree Fund Advisors
Northern Trust
Jones Financial Companies, L.L
HighTower Advisors
Foundations Investment Advisors
SLT Holdings

View all funds holding Bioxcel Therapeutics